Catalyst Wire Dossier Catalyst Wire Dossier

24-valent pneumococcal polysaccharide conjugate vaccine

pneumococcal polysaccharide conjugate vaccine (24-valent)
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for 24-valent pneumococcal polysaccharide conjugate vaccine, covering 2025-06-18 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine [Phase 2]

See pricing